Trials / Recruiting
RecruitingNCT02917707
Integrative Analysis of CRC Liver Metastasis
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,000 (estimated)
- Sponsor
- Da Fu · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The investigators will perform integrative analysis of CRC liver metastasis
Detailed description
The investigators will analyzed proteomes of paired normal colorectal tissues and colorectal cancer (CRC) with or without liver metastasis, sequenced transcriptomes, performed whole exome sequencing, and single nucleotide polymorphism (SNP) array profiling for triplets, each comprising normal colorectal tissue, primary colorectal carcinoma, and its synchronous matched liver metastasis, as well as analyzed genomics of CRC characterized previously by The Cancer Genome Atlas (TCGA) to conduct integrated proteogenomic analyses.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | normal colorectal tissues | The investigators will extract total protein, DNA and RNA from these groups. |
Timeline
- Start date
- 2016-01-01
- Primary completion
- 2026-12-01
- Completion
- 2026-12-01
- First posted
- 2016-09-28
- Last updated
- 2016-09-28
Locations
2 sites across 1 country: China
Source: ClinicalTrials.gov record NCT02917707. Inclusion in this directory is not an endorsement.